Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bela Merkely

Showing results (161-170 of 296) with videos related to

Pageof 30
Sort By:
The New England Journal of Medicine|September 15, 2006
Sirolimus-eluting versus uncoated stents in acute myocardial infarctionChristian Spaulding, Patrick Henry, Emmanuel Teiger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trialBela Merkely, Annamaria Kosztin, Attila Roka, et al.
Heart Rhythm|August 27, 2013
Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-DValentina Kutyifa, Poul Erik Bloch Thomsen, David T Huang, et al.
American Heart Journal|March 30, 2013
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarctionAnjan K Chakrabarti, Kristin Feeney, Cassandra Abueg, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 9, 2026
From Sedentary Individuals to Highly Trained Athletes: A Comprehensive Cardiovascular Magnetic Resonance Imaging Study of Cardiac Volumetry, Function, and StrainLiliana Szabo, Vencel Juhasz, Dorottya Balla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Renin-angiotensin-aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitorsZsofia D Drobni, Olivier Michielin, Thiago Quinaglia, et al.
European Heart Journal|November 21, 2015
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary interventionC Michael Gibson, Robert P Giugliano, Robert A Kloner, et al.
American Heart Journal|September 24, 2016
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarctionC Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 20, 2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialStephen J Nicholls, Rishi Puri, Kathy Wolski, et al.
Scientific Reports|December 15, 2022
Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infectionMate Babity, Mark Zamodics, Albert Konig, et al.
Pageof 30

Showing results (161-170 of 296) with videos related to

Sort By:
Pageof 30
The New England Journal of Medicine|September 15, 2006
Sirolimus-eluting versus uncoated stents in acute myocardial infarctionChristian Spaulding, Patrick Henry, Emmanuel Teiger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trialBela Merkely, Annamaria Kosztin, Attila Roka, et al.
Heart Rhythm|August 27, 2013
Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-DValentina Kutyifa, Poul Erik Bloch Thomsen, David T Huang, et al.
American Heart Journal|March 30, 2013
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarctionAnjan K Chakrabarti, Kristin Feeney, Cassandra Abueg, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 9, 2026
From Sedentary Individuals to Highly Trained Athletes: A Comprehensive Cardiovascular Magnetic Resonance Imaging Study of Cardiac Volumetry, Function, and StrainLiliana Szabo, Vencel Juhasz, Dorottya Balla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2022
Renin-angiotensin-aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitorsZsofia D Drobni, Olivier Michielin, Thiago Quinaglia, et al.
European Heart Journal|November 21, 2015
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary interventionC Michael Gibson, Robert P Giugliano, Robert A Kloner, et al.
American Heart Journal|September 24, 2016
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarctionC Michael Gibson, Serge Korjian, Pierluigi Tricoci, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 20, 2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialStephen J Nicholls, Rishi Puri, Kathy Wolski, et al.
Scientific Reports|December 15, 2022
Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infectionMate Babity, Mark Zamodics, Albert Konig, et al.
Pageof 30